Declaration of interests: Karen Quigley
Declaration of interests: Karen Quigley
Declaration of interests: Karen Quigley
Declaration of interests: Virginia Rojo Guerra
Herbal medicinal product: Cannabis flos, Cannabis sativa L., D: Draft under discussion
Appendix 1: Acceptable intakes established for N-nitrosamines
Overview of comments received on the draft qualification opinion for Simcyp Simulator
Qualification opinion for Simcyp Simulator
Human medicines European public assessment report (EPAR): Saxenda, liraglutide, Date of authorisation: 23/03/2015, Revision: 19, Status: Authorised
List of EU Medicines Regulatory Agency Organisation with single and multiple LOC IDs for Product Management Services (PMS) data enrichment - Chapter 2 Annex III
PSUSA/00000832/202411
Highlight report - 14th meeting of the industry stakeholder platform on the operation of the centralised procedure for human medicines